Ito K, Sasaki K, Ono M, et al. Investigation of real-world heparin resistance and anticoagulation management prior to cardiopulmonary bypass: report from a nationwide survey by the Japanese Association for Thoracic Surgery heparin resistance working group. Gen Thorac Cardiovasc Surg. 2023. https://doi.org/10.1007/s11748-023-01936-5. (Online ahead of print).
Article PubMed PubMed Central Google Scholar
Bull BS, Huse WM, Brauer FS, et al. Heparin therapy during extracorporeal circulation. II. The use of a dose-response curve to individualize heparin and protamine dosage. J Thorac Cardiovasc Surg. 1975;69:685–9.
Article CAS PubMed Google Scholar
Shore-Lesserson L, Baker RA, Ferraris V, et al. STS/SCA/AmSECT clinical practice guidelines: anticoagulation during cardiopulmonary bypass. J Extra Corpor Technol. 2018;50:5–18.
Article PubMed PubMed Central Google Scholar
Esposito RA, Culliford AT, Colvin SB, Thomas SJ, Lackner H, Spencer FC. Heparin resistance during cardiovascular bypass: the role of heparin pretreatment. J Thorac Cardiovasc Surg. 1983;85:346–53.
Article CAS PubMed Google Scholar
Anderson EF. Heparin resistance prior to cardiopulmonary bypass. Anesthesiology. 1986;64:504–7.
Article CAS PubMed Google Scholar
Staples MH, Dunton RF, Karlson KJ, Leonardi HK, Berger RL. Heparin resistance after preoperative heparin therapy or intraaortic balloon pumping. Ann Thorac Surg. 1994;57:1211–6.
Article CAS PubMed Google Scholar
Ranucci M, Isgrò G, Cazzaniga A, Soro G, Menicanti L, Frigiola A. Predictors for heparin resistance in patients undergoing coronary artery bypass grafting. Perfusion. 1999;14:437–42.
Article CAS PubMed Google Scholar
Ranucci M, Isgrò G, Cazzaniga A, Ditta A, Boncilli A, Cotza M, et al. Different patterns of heparin resistance: therapeutic implications. Perfusion. 2002;17:199–204.
Garvin S, Fitzgerald D, Muehlschlegel JD, Perry TE, Fox AA, Shernan SK, et al. Heparin dose response is independent of preoperative AT activity in patients undergoing coronary artery bypass graft surgery using low heparin concentrations. Anesth Analg. 2010;111:856–61.
Article CAS PubMed PubMed Central Google Scholar
Finley A, Greenberg C. Heparin sensitivity and resistance: management during cardiopulmonary bypass. Anesth Analg. 2013;116:1210–22.
Article CAS PubMed Google Scholar
Kawatsu S, Sasaki K, Sakatsume K, Takahara S, Hosoyama K, Masaki N, et al. Predictors of heparin resistance before cardiovascular operations in adults. Ann Thorac Surg. 2018;105:1316–21.
Yamashiro T, Hibiya M, Takagi Y, et al. Study on influencing. factors on heparin reactivity. Jpn J Extra Corpor Technol. 2020;47:115–21.
Voelker R. New standards reduce heparin potency. JAMA. 2009;302:1956.
Article CAS PubMed Google Scholar
Hirsh J, Warkentin TE, Dalen JE, et al. Heparin and low-molecular-weight heparin: mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest. 2001;119:64S-94S.
Article CAS PubMed Google Scholar
Sobel M, McNeill PM, Marques D, et al. Heparin inhibition of von Willebrand factor-dependent platelet function in vitro and in vivo. J Clin Investig. 1991;87:1787–93.
Article CAS PubMed PubMed Central Google Scholar
Mohri H, Ohkubo T. Fibrinogen binds to heparin: the relationship of the binding of other adhesive proteins to heparin. Arch Biochem Biophys. 1993;303:27–31.
Article CAS PubMed Google Scholar
Fredenburgh JC, Leslie BA, Stafford AR, Lim T, Chan HH, Weitz JI. Zn2+ mediates high affinity binding of heparin to the αC domain of fibrinogen. J Biol Chem. 2013;288:29394–402.
Article CAS PubMed PubMed Central Google Scholar
Chan HH, Leslie BA, Stafford AR, Roberts RS, Al-Aswad NN, Fredenburgh JC, Weitz JI. By increasing the affinity of heparin for fibrin, Zn(2+) promotes the formation of a ternary heparin-thrombin-fibrin complex that protects thrombin from inhibition by antithrombin. Biochemistry. 2012;51:7964–73.
Article CAS PubMed Google Scholar
Chan T, Hwang NC, Lim CH. A statistical analysis of factors predisposing patients to heparin resistance. Perfusion. 2006;21:99–103.
Jøorgensen KA, Stoffersen E. Heparin like activity of albumin. Thromb Res. 1979;16:569–74.
Jørgensen KA, Stoffersen E. On the inhibitory effect of albumin on platelet aggregation. Thromb Res. 1980;17:13–8.
Galanakis DK. Anticoagulant albumin fragments that bind to fibrinogen/fibrin: possible implications. Semin Thromb Hemost. 1992;18:44–52.
Article CAS PubMed Google Scholar
King AB, O’Duffy AE, Kumar AB. Heparin resistance and anticoagulation failure in a challenging case of cerebral venous sinus thrombosis. Neurohospitalist. 2016;6:118–21.
Society of Thoracic Surgeons Blood Conservation Guideline Task Force, Ferraris VA, Brown JR, Despotis GJ, et al. 2011 update to the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists blood conservation clinical practice guidelines. Ann Thorac Surg. 2011;91:944–82.
Sniecinski RM, Bennett-Guerrero E, Shore-Lesserson L. Anticoagulation management and heparin resistance during cardiopulmonary bypass: a survey of Society of Cardiovascular Anesthesiologists Members. Anesth Analg. 2019;129:e41–4.
Article CAS PubMed Google Scholar
Danielsson A, Raub E, Bjork I, et al. Role of ternary complexes, in which heparin binds both antithrombin and proteinase, in the acceleration of the reactions between antithrombin and thrombin or factor Xa. J Biol Chem. 1986;261:15467–73.
Article CAS PubMed Google Scholar
Huang ZF, Wun T-C, Broze GJ Jr. Kinetics of factor Xa inhibition by tissue factor pathway inhibitor. J Biol Chem. 1993;268:26950–5.
Article CAS PubMed Google Scholar
Treichl B, Bachler M, Lorenz I, et al. Efficacy of argatroban in critically ill patients with heparin resistance: a retrospective analysis. Semin Thromb Hemost. 2015;41:61–7.
Comments (0)